Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH)

Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2

Postulated mechanisms on decrease in hepatic lipid synthesis by an

A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified

Medicina, Free Full-Text

Nonalcoholic Fatty Liver Disease: The Overlooked Complication of

Pharmacotherapy for Non-alcoholic Fatty Liver Disease Associated

Therapeutic Strategies for Metabolic Diseases: Small‐Molecule

New Drugs on the Block—Emerging Treatments for Nonalcoholic

The effect of CpdB on diabetes and obesity in HFD‐fed ob/ob mice